SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14C - Other definitive information statements:
SEC Accession No. 0001193125-13-187573
Filing Date
2013-04-30
Accepted
2013-04-30 16:43:49
Documents
5
Period of Report
2013-04-22
Effectiveness Date
2013-04-30

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 14C d523645ddef14c.htm DEF 14C 203969
2 EX99.(A) d523645dex99a.htm EX-99.(A) 1975
3 EX-99.(B) d523645dex99b.htm EX-99.(B) 68438
4 EX-99(C) d523645dex99c.htm EX-99.(C) 55564
5 EX-99.(D) d523645dex99d.htm EX-99.(D) 4442
  Complete submission text file 0001193125-13-187573.txt   335410
Mailing Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540 (609) 243-0123
Celator Pharmaceuticals Inc (Filer) CIK: 0001327467 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14C | Act: 34 | File No.: 000-54852 | Film No.: 13798282
SIC: 2834 Pharmaceutical Preparations